Wealth Enhancement Advisory Services, LLC Ionis Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 7,915 shares of IONS stock, worth $336,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,915Holding current value
$336,783% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
404Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$697 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$688 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$526 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$439 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$358 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.04B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...